Cited 27 times in
Resveratrol Inhibits Hypoxia-Induced Vascular Endothelial Growth Factor Expression and Pathological Neovascularization
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 고형준 | - |
dc.contributor.author | 이성철 | - |
dc.contributor.author | 이승규 | - |
dc.date.accessioned | 2018-03-26T17:14:11Z | - |
dc.date.available | 2018-03-26T17:14:11Z | - |
dc.date.issued | 2015 | - |
dc.identifier.issn | 0513-5796 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/157388 | - |
dc.description.abstract | PURPOSE: To investigate the effects of resveratrol on the expression of hypoxia-inducible factor 1α (HIF-1α) and vascular endothelial growth factor (VEGF) in human adult retinal pigment epithelial (ARPE-19) cells, and on experimental choroidal neovascularization (CNV) in mice. MATERIALS AND METHODS: ARPE-19 cells were treated with different concentrations of resveratrol and then incubated under hypoxic conditions with subsequent evaluation of cell viability, expression of HIF-1α, and expression of VEGF. The effects of resveratrol on the synthesis and degradation of hypoxia-induced HIF-1α were evaluated using inhibitors of the PI3K/Akt/mTOR and the ubiquitin proteasome pathways. In animal studies, CNV lesions were induced in C57BL/6 mice by laser photocoagulation. After 7 days of oral administration of resveratrol or vehicle, which began one day after CNV induction, image analysis was used to measure CNV areas on choroidal flat mounts stained with isolectin IB4. RESULTS: In ARPE-19 cells, resveratrol significantly inhibited HIF-1α and VEGF in a dose-dependent manner, by blocking the PI3K/Akt/mTOR signaling pathway and by promoting proteasomal HIF-1α degradation. In mice experiments, orally administered resveratrol significantly inhibited CNV growth in a dose-dependent manner. CONCLUSION: Resveratrol may have therapeutic value in the management of diseases involving pathological neovascularization. | - |
dc.description.statementOfResponsibility | open | - |
dc.language | English | - |
dc.publisher | Yonsei University | - |
dc.relation.isPartOf | YONSEI MEDICAL JOURNAL | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Adult | - |
dc.subject.MESH | Animals | - |
dc.subject.MESH | Cell Survival/drug effects | - |
dc.subject.MESH | Choroidal Neovascularization/metabolism* | - |
dc.subject.MESH | Choroidal Neovascularization/pathology | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Hypoxia/metabolism | - |
dc.subject.MESH | Hypoxia/physiopathology | - |
dc.subject.MESH | Hypoxia-Inducible Factor 1, alpha Subunit/drug effects* | - |
dc.subject.MESH | Hypoxia-Inducible Factor 1, alpha Subunit/metabolism | - |
dc.subject.MESH | Mice | - |
dc.subject.MESH | Mice, Inbred C57BL | - |
dc.subject.MESH | Phosphatidylinositol 3-Kinases/antagonists & inhibitors | - |
dc.subject.MESH | Phosphatidylinositol 3-Kinases/physiology* | - |
dc.subject.MESH | Proteasome Endopeptidase Complex | - |
dc.subject.MESH | Proto-Oncogene Proteins c-akt/antagonists & inhibitors | - |
dc.subject.MESH | Proto-Oncogene Proteins c-akt/physiology* | - |
dc.subject.MESH | Retinal Pigment Epithelium/drug effects* | - |
dc.subject.MESH | Retinal Pigment Epithelium/metabolism | - |
dc.subject.MESH | Signal Transduction | - |
dc.subject.MESH | Stilbenes/administration & dosage | - |
dc.subject.MESH | Stilbenes/pharmacology* | - |
dc.subject.MESH | TOR Serine-Threonine Kinases/antagonists & inhibitors | - |
dc.subject.MESH | TOR Serine-Threonine Kinases/physiology* | - |
dc.subject.MESH | Ubiquitin | - |
dc.subject.MESH | Vascular Endothelial Growth Factor A/drug effects* | - |
dc.subject.MESH | Vascular Endothelial Growth Factor A/metabolism | - |
dc.title | Resveratrol Inhibits Hypoxia-Induced Vascular Endothelial Growth Factor Expression and Pathological Neovascularization | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine | - |
dc.contributor.department | Dept. of Ophthalmology | - |
dc.contributor.googleauthor | Christopher Seungkyu Lee | - |
dc.contributor.googleauthor | Eun Young Choi | - |
dc.contributor.googleauthor | Sung Chul Lee | - |
dc.contributor.googleauthor | Hyoung Jun Koh | - |
dc.contributor.googleauthor | Joon Haeng Lee | - |
dc.contributor.googleauthor | Ji Hyung Chung | - |
dc.identifier.doi | 10.3349/ymj.2015.56.6.1678 | - |
dc.contributor.localId | A00152 | - |
dc.contributor.localId | A02873 | - |
dc.contributor.localId | A02913 | - |
dc.relation.journalcode | J02813 | - |
dc.identifier.eissn | 1976-2437 | - |
dc.identifier.pmid | 26446654 | - |
dc.subject.keyword | Choroidal neovascularization | - |
dc.subject.keyword | hypoxia-inducible factor-1 | - |
dc.subject.keyword | resveratrol | - |
dc.subject.keyword | retinal pigment epithelium | - |
dc.subject.keyword | vascular endothelial growth factor | - |
dc.contributor.alternativeName | Koh, Hyoung Jun | - |
dc.contributor.alternativeName | Lee, Sung Chul | - |
dc.contributor.alternativeName | Lee, Seung Kyu | - |
dc.contributor.affiliatedAuthor | Koh, Hyoung Jun | - |
dc.contributor.affiliatedAuthor | Lee, Sung Chul | - |
dc.contributor.affiliatedAuthor | Lee, Seung Kyu | - |
dc.citation.volume | 56 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 1678 | - |
dc.citation.endPage | 1685 | - |
dc.identifier.bibliographicCitation | YONSEI MEDICAL JOURNAL, Vol.56(6) : 1678-1685, 2015 | - |
dc.identifier.rimsid | 42413 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.